Related Experiment Videos
Sole pulmonary involvement by Langerhans' cell histiocytosis in a child
J M Chatkin1, J C Bastos, R T Stein
1Hospital São Lucas, School of Medicine, Pontificia Universidade Catolica do Rio Grande do Sul, Porto Alegre, Brazil.
Insights
A rare case of Langerhans' cell histiocytosis (LCH) in a young boy presented as sudden pneumothorax. Despite treatment, the child succumbed to the aggressive, isolated lung disease.
Area of Science:
- Pediatric Pulmonology
- Pediatric Oncology
- Histiocytosis
Background:
- Langerhans' cell histiocytosis (LCH) is a rare clonal proliferative disorder of myeloid dendritic cells.
- Pulmonary involvement in pediatric LCH can be primary or secondary, presenting diverse clinical manifestations.
- Isolated pulmonary LCH without prior respiratory symptoms is exceptionally uncommon.
Observation:
- A 4-year-old boy presented with sudden onset pneumothorax, with no preceding respiratory illness.
- Diagnostic confirmation involved S-100 and MT1 antibody staining, identifying Langerhans' cells.
- The disease manifested as isolated pulmonary involvement.
Findings:
- The patient received treatment with pulse steroids and multiple pleural drainages.
- Despite interventions, the disease progressed rapidly.
- A large bilateral pneumothorax led to a fatal outcome.
Implications:
- This case highlights the potential for aggressive, isolated pulmonary LCH in children.
- Early recognition and diagnosis are crucial, even with atypical presentations.
- Further research into optimal therapeutic strategies for pediatric pulmonary LCH is warranted.
Abstract:
The case of a boy aged 4 yrs and 7 months, with isolated pulmonary involvement by Langerhans' cell histiocytosis is reported. The presentation of the disease was a sudden pneumothorax, with no previous signs of respiratory disease. The case was confirmed by S-100 and MT1 antibody staining, and was treated with pulse steroids and several pleural drainages, until the boy died after a large bilateral pneumothorax.